初级保健 POC 诊断市场 - 副产品（血糖监测、心臟代谢、尿液分析、胆固醇、传染病、癌症标记、凝血、血液学、妊娠和生育检测产品）、最终用途 - 全球预测，2024-2032 年

Primary Care POC Diagnostics Market - By Product (Glucose Monitoring, Cardiometabolic, Urinalysis, Cholesterol, Infectious Disease, Cancer Marker, Coagulation, Hematology, Pregnancy & Fertility Testing Products), End-use - Global Forecast, 2024-2032

出版日期: 2024年01月16日 | 出版商:

Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在技术进步以及对快速准确诊断解决方案不断增长的需求的推动下，全球初级保健即时诊断 (POC) 市场预计在 2024 年至 2032 年将以 7% 的速度增长。

据世界卫生组织称，非传染性疾病每年夺走 4,100 万人的生命，占全球死亡人数的 74%。老年人口的不断增加，加上糖尿病、心血管疾病和传染病等慢性病的盛行率不断上升，推动了对 POC 诊断工具的需求。此外，随着技术的进步（例如便携式诊断设备的开发），对分散诊断测试的需求不断增长，提高了患者的便利性并推动了采用率。

人们对疾病早期诊断的认识有所提升。这一因素加上有利的政府倡议和报销政策，正在鼓励医疗保健提供者将 POC 诊断融入其实践中，从而促进市场扩张。

整个初级保健 POC 诊断行业根据产品、最终用途和地区进行分类。

预计到 2032 年，心臟代谢领域将以相当快的速度扩张。随着全球心血管疾病和糖尿病盛行率的不断上升，初级保健机构对快速、可靠的诊断解决方案的需求日益增长。该公司正在大力投资开发针对心臟标记、血脂检测和 HbA1c 等疾病的 POC 诊断测试，使医疗保健提供者能够及时采取干预措施并改善患者的治疗结果。

诊断中心部门预计到 2032 年将强劲成长，因为它们为当地社区的患者提供广泛的测试和服务。随着技术的进步和便携式诊断设备的日益普及，诊断中心现在能够提供扩展的 POC 测试菜单，满足患者和医疗保健提供者的不同需求。因此，诊断中心预计将在未来几年实现显着成长。

在庞大的人口基数、不断增长的医疗保健支出以及人们对预防性医疗保健意识不断提高的推动下，亚太地区初级保健定点医疗 (POC) 诊断市场将在研究期间获得显着地位。中国、印度和日本等国家的医疗基础设施正在快速扩张，越来越多的初级保健诊所和诊断中心采用 POC 检测技术，推动了产业成长。

产业生态系统分析
技术景观
监管环境
产业影响力
- 成长动力
  - 疾病盛行率呈上升趋势和对快速诊断的需求
  - POCT设备的技术进步
  - 加大研发投入
- 产业陷阱与挑战
  - 严格的监管框架
  - 产品开发成本高
成长潜力分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
战略展望矩阵

第 5 章：初级保健 POC 诊断市场规模和预测：按产品划分，2018-2032 年

主要动向：按产品
血糖监测
心臟代谢检测产品
- 心臟标记检测产品
  - 超敏肌钙蛋白
  - 法国巴黎银行
  - D-二聚体
  - CK-MB
  - 肌红蛋白
  - 其他心臟市场测试产品
- 血气/电解质检测产品
- HBA1C检测产品
传染病检测产品
- 流感检测产品
- HIV检测产品
- 丙型肝炎检测产品
- 性传染病 (STD) 检测产品
- 医疗保健相关感染 (HAI) 检测产品
- 呼吸道感染检测产品
- 热带疾病检测产品
- 其他传染病检测产品
凝血检测产品
- PT/INR检测产品
- 活化凝血时间（ACT/APTT）检测产品
怀孕和生育测试产品
- 验孕产品
- 生育力检测产品
肿瘤/癌症标记检测产品
胆固醇检测产品
血液学检测产品
滥用药物 (DoA) 检测产品
粪便隐匿性检测产品
尿液分析检测产品
其他产品

第 6 章：初级保健 POC 诊断市场规模和预测：按最终用途分类，2018-2032 年

主要动向：依最终用途
医院
诊断中心
研究实验室
居家照护环境
其他最终用户

第 7 章：初级保健 POC 诊断市场规模和预测：按地区划分，2018-2032 年

主要动向：按地区
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Abbott Laboratories
ACON Laboratories, Inc.
Becton, Dickinson, and Company
BioMerieux SA
Bio-Rad Laboratories, Inc.
Dexcom, Inc.
Dragerwerk Ag & Co.
F. Hoffmann-La Roche
HemoCue AB (Danaher Corporation)
Nova Biomedical
Siemens Healthineers AG
Sysmex Corporation

简介目录

Product Code: 7895

The global primary care point-of-care (POC) diagnostics market is expected to grow at a rate of 7% during 2024 and 2032, driven by technological advancements, and the growing demand for rapid & accurate diagnostic solutions.

According to WHO, NCDs claim 41 million lives annually, comprising 74% of global fatalities. The rising geriatric population, coupled with the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases is pushing the demand for POC diagnostic tools. Additionally, the growing demand for decentralized diagnostic testing, in consort with the advancements in technology, such as the development of portable diagnostic devices, are enhancing patient convenience and driving adoption rates.

There is improved awareness about the early diagnosis of ailments. This factor, alongside favorable government initiatives and reimbursement policies are encouraging healthcare providers to integrate POC diagnostics into their practices, fostering market expansion.

The overall primary care POC diagnostics industry is classified based on product, end-use, and region.

The cardiometabolic segment is anticipated to expand at a decent pace till 2032. With the rising prevalence of cardiovascular diseases and diabetes worldwide, there is a growing need for rapid and reliable diagnostic solutions in primary care settings. Companies are investing heavily in the development of POC diagnostic tests for conditions such as cardiac markers, lipid panels, and HbA1c, empowering healthcare providers to make timely interventions and improve patient outcomes.

The diagnostic centers segment is poised to grow robustly through 2032, as they offer a wide range of tests and services to patients in their local communities. With advancements in technology and the increasing availability of portable diagnostic devices, diagnostic centers are now able to offer an expanded menu of POC tests, catering to the diverse needs of patients and healthcare providers alike. As a result, diagnostic centers are poised to experience significant growth in the coming years.

Asia Pacific primary care point-of-care (POC) diagnostics market is set to gain prominence during the study period, propelled by the large population base, coupled with rising healthcare expenditures, and increasing awareness about preventive healthcare. Countries such as China, India, and Japan are witnessing a rapid expansion of their healthcare infrastructure, with a growing number of primary care clinics and diagnostic centers adopting POC testing technologies, thereby fueling industry growth.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Base estimates and working
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global primary care POC diagnostics market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Product trends
- 2.1.3 End-use trends

Chapter 3 Primary Care POC Diagnostics Industry Insights

3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
- 3.4.1 Growth drivers
  - 3.4.1.1 Upward trend in disease prevalence and demand for quick diagnostics
  - 3.4.1.2 Technological advancements in POCT devices
  - 3.4.1.3 Increasing R&D investment
- 3.4.2 Industry pitfalls and challenges
  - 3.4.2.1 Stringent regulatory framework
  - 3.4.2.2 High cost of product development
3.5 Growth potential analysis
- 3.5.1 By product
- 3.5.2 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023

Chapter 5 Primary Care POC Diagnostics Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1 Key trends, by product
5.2 Glucose monitoring
5.3 Cardiometabolic testing products
- 5.3.1 Cardiac marker testing products
  - 5.3.1.1 hsTnl
  - 5.3.1.2 BNP
  - 5.3.1.3 D-dimer
  - 5.3.1.4 CK-MB
  - 5.3.1.5 Myoglobin
  - 5.3.1.6 Other cardiac market testing products
- 5.3.2 Blood gas/electrolytes testing products
- 5.3.3 HBA1C testing products
5.4 Infectious disease testing products
- 5.4.1 Influenza testing products
- 5.4.2 HIV testing products
- 5.4.3 Hepatitis C testing products
- 5.4.4 Sexually transmitted disease (STD) testing products
- 5.4.5 Healthcare-associated infection (HAI) testing products
- 5.4.6 Respiratory infection testing products
- 5.4.7 Tropical disease testing products
- 5.4.8 Other infectious disease testing products
5.5 Coagulation testing products
- 5.5.1 PT/INR testing products
- 5.5.2 Activated clotting time (ACT/APTT) testing products
5.6 Pregnancy and fertility testing products
- 5.6.1 Pregnancy testing products
- 5.6.2 Fertility testing products
5.7 Tumor/cancer marker testing products
5.8 Cholesterol testing products
5.9 Hematology testing products
5.10 Drug-of-abuse (DoA) testing products
5.11 Fecal occult testing products
5.12 Urinalysis testing products
5.13 Other products

Chapter 6 Primary Care POC Diagnostics Market Size and Forecast, By End-Use, 2018-2032 (USD Million)

6.1 Key trends, by end-use
6.2 Hospitals
6.3 Diagnostic centers
6.4 Research laboratories
6.5 Home-care settings
6.6 Other end-users

Chapter 7 Primary Care POC Diagnostics Market Size and Forecast, By Region, 2018-2032 (USD Million)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa